PK and Tolerability of CKD-348 vs Co-administered Drugs in Healthy Volunteers

Phase 1, randomised, open-label trial of Levamlodipine, telmisartan, rosuvastatin and ezetimibe in hypertension (HTN) and dyslipidemia (6 arms), sponsored by Chong Kun Dang Holdings. Primary endpoints: Area Under the Concentration-time Curve from time 0 to the last measurable concentration at 72 hours and Maximum Plasma Concentration at 72 hours. Started Mar 2020; status: completed.